Restructuring Focused Group Rankings

So how would you guys rank these banks strictly based on opportunities to Distressed Hedge Fund/ PE firms?

I figure Blackstone and Lazard are at the top, but I have an opportunity to pursue with a couple of the firms listed below and wanted to see where it sizes up:

Evercore
Moelis
Centerview
P J Solomon
Miller Buckfire
Millstein
Greenhill
Rothschild
Guggenheim
Imperial
Chanin (D&P's Rx arm)

This is strictly for the restructuring practices of each firm listed. Again not really trying to rank which one is marginally better than the other, but perhaps a tier system? Just to see which ones have possibilities for distressed buy-side options.

LinkedIn provided very little in terms of strictly distressed buy-side opportunities, btw.

Thanks for all the help.

 
Best Response

Most of the full advisory service banks: Greenhill, Centerview, Evercore, Moelis have some good placement stats, from what I can tell. What I think a lot of people would like to know is how are they in strictly rx>distressed shops?

And on top of that what is really my concern are the other that are listed. Where do they fall in regards to buy-side opportunities, again strictly distressed shops? Just figured it would be good to get some input as there are many individuals interested in this space over a M&A position.

 

It's enough of a technical business that if you have a couple years of experience and want to go to the buyside, you can. But restructuring is also small enough community that everybody knows everyone else, so having a reference from the senior guy on your team, or even someone you worked with (I know a guy who listed the biglaw partner he worked with on a complex situation as a reference since his firm frowned on leaving) is critical. Moreso when you realize that you can spend a whole year on a single transaction.

In NYC, Lazard is the gold standard for resumes (part of this is that everyone leaves, not necessarily true other places). BX is also excellent, and Greenhill, Evercore and Miller Buckfire have historically placed well (Miller Buckfire's issues could hurt its positioning going forward). HLHZ is like being in a sponsors group, because of all the creditor work you get to know the firms you will be interviewing with better. Centerview doesn't really have restructuring analysts so it is hard to tell. Moelis has a lot of people leave, and some place well, while others don't. Guggenheim is relatively new and has been promising in-house laterals, unknown if they will materialize. Rothschild is great in London but a more limited presence in NYC. PJS and PWP (not on the original list) will teach you the business, but you will need to network and interview well to get some of the more competitive spots.

 

Thanks monkeyc

I didn't want this to be a BX/LAZ/HLHZ convo, because from those positions I feel like most doors are open and its up to you to get in.

That's interesting, I would think PWP would have great opportunities. Could you expand on Miller 's issues?

Also, if any one knows, how do these firms stack up for Business School?

Thanks again guys.

 

Centerview has only worked on 1 deal rx deal so far, not really fully established as a rx shop yet. In a few years when their dealflow picks up, when they hire more people for rx, then it'll be a really good platform for analysts. Until then you will probably be doing majority strategy and m&a work there.

 

The thread is old but bumping it to clear the misinformation that's spread.

Currently interviewing as a lateral for top RX boutiques and I can tell you that Laz, HL, & PJT have the most prominent RX practices in the industry. Every year Laz and HL are generally first in the league tables. If there is a high profile transaction going on you can bet that HL and either Laz/PJT will be involved.

Exits are also fantastic for all the three groups. Unclear how exits will change for PJT after the spin-off but these three groups are generally the primary hunting ground for distressed PE/HF. RX is also viewed as super technical so they will also open up doors to the top non-distressed funds too.

If you can't land Laz/HL/PJT you want to look at Rothschild/Evercore/Moelis.

If the above firms are not an option and you are serious about RX then you are better off going to a good RX focused boutique like Millstein, Miller Buckfire, Imperial, GLC etc.

PJSC is okay and they do some work, PWP's team is dissolving, Centerview and Greenhill are decent but more known for M&A. Better to go to a shop that is well known for what you want to do.

 

Totam provident voluptates fuga autem accusamus velit. Deserunt consequatur a omnis. Omnis sed facilis occaecati praesentium et debitis nihil.

Est id deleniti esse iste vel saepe. Perspiciatis voluptatem quod quisquam ut quis commodi. Dicta sapiente assumenda vel expedita consequatur esse hic dicta. Possimus ducimus occaecati soluta omnis. Officiis sit quam quos.

Quam saepe tenetur sit necessitatibus. Cum nihil repellendus sit dicta adipisci odio a. Omnis vero voluptas minus totam provident vel. Recusandae veritatis non et minus tempore optio itaque.

Maiores vel dolor quo rem enim. Magni ut et ea adipisci ea quasi velit. Delectus nemo occaecati vel sit vitae magni eum quam.

Career Advancement Opportunities

March 2024 Investment Banking

  • Jefferies & Company 02 99.4%
  • Goldman Sachs 19 98.8%
  • Harris Williams & Co. (++) 98.3%
  • Lazard Freres 02 97.7%
  • JPMorgan Chase 03 97.1%

Overall Employee Satisfaction

March 2024 Investment Banking

  • Harris Williams & Co. 18 99.4%
  • JPMorgan Chase 10 98.8%
  • Lazard Freres 05 98.3%
  • Morgan Stanley 07 97.7%
  • William Blair 03 97.1%

Professional Growth Opportunities

March 2024 Investment Banking

  • Lazard Freres 01 99.4%
  • Jefferies & Company 02 98.8%
  • Goldman Sachs 17 98.3%
  • Moelis & Company 07 97.7%
  • JPMorgan Chase 05 97.1%

Total Avg Compensation

March 2024 Investment Banking

  • Director/MD (5) $648
  • Vice President (19) $385
  • Associates (86) $261
  • 3rd+ Year Analyst (13) $181
  • Intern/Summer Associate (33) $170
  • 2nd Year Analyst (66) $168
  • 1st Year Analyst (202) $159
  • Intern/Summer Analyst (144) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Secyh62's picture
Secyh62
99.0
3
Betsy Massar's picture
Betsy Massar
99.0
4
BankonBanking's picture
BankonBanking
99.0
5
kanon's picture
kanon
98.9
6
CompBanker's picture
CompBanker
98.9
7
dosk17's picture
dosk17
98.9
8
DrApeman's picture
DrApeman
98.9
9
GameTheory's picture
GameTheory
98.9
10
bolo up's picture
bolo up
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”